Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A

Bloodstream infections in low- and middle-income countries (LMICs) are most frequently attributed to invasive Salmonella disease caused by four primary serovars of <i>Salmonella</i> enterica: Typhi, Paratyphi A, Typhimurium, and Enteritidis. We showed previously that a bivalent vaccine t...

Full description

Bibliographic Details
Main Authors: Emily M. Boerth, Joyce Gong, Becky Roffler, Claudette M. Thompson, Boni Song, Sasha F. Malley, Angelika Hirsch, Calman A. MacLennan, Fan Zhang, Richard Malley, Ying-Jie Lu
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/11/1671
_version_ 1797457566534467584
author Emily M. Boerth
Joyce Gong
Becky Roffler
Claudette M. Thompson
Boni Song
Sasha F. Malley
Angelika Hirsch
Calman A. MacLennan
Fan Zhang
Richard Malley
Ying-Jie Lu
author_facet Emily M. Boerth
Joyce Gong
Becky Roffler
Claudette M. Thompson
Boni Song
Sasha F. Malley
Angelika Hirsch
Calman A. MacLennan
Fan Zhang
Richard Malley
Ying-Jie Lu
author_sort Emily M. Boerth
collection DOAJ
description Bloodstream infections in low- and middle-income countries (LMICs) are most frequently attributed to invasive Salmonella disease caused by four primary serovars of <i>Salmonella</i> enterica: Typhi, Paratyphi A, Typhimurium, and Enteritidis. We showed previously that a bivalent vaccine targeting <i>S</i>. Typhi and <i>S</i>. Paratyphi A using a Multiple Antigen-Presenting System (MAPS) induced functional antibodies against <i>S</i>. Typhi and <i>S</i>. Paratyphi. In the current study, we describe the preclinical development of a first candidate quadrivalent combination <i>Salmonella</i> vaccine with the potential to cover all four leading invasive <i>Salmonella</i> serotypes. We showed that the quadrivalent <i>Salmonella</i> MAPS vaccine, containing Vi from <i>S</i>. Typhi, O-specific Polysaccharide (OSP) from <i>S.</i> Paratyphi A, <i>S.</i> Enteritidis and <i>S.</i> Typhimurium, combined with the <i>Salmonella</i>-specific protein SseB, elicits robust and functional antibody responses to each of the components of the vaccine. Our data indicates that the application of MAPS technology to the development of vaccines targeting invasive forms of Salmonella is practical and merits additional consideration.
first_indexed 2024-03-09T16:23:53Z
format Article
id doaj.art-aac55b36e4d74c2fb309acdad01b108d
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T16:23:53Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-aac55b36e4d74c2fb309acdad01b108d2023-11-24T15:10:01ZengMDPI AGVaccines2076-393X2023-10-011111167110.3390/vaccines11111671Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi AEmily M. Boerth0Joyce Gong1Becky Roffler2Claudette M. Thompson3Boni Song4Sasha F. Malley5Angelika Hirsch6Calman A. MacLennan7Fan Zhang8Richard Malley9Ying-Jie Lu10Division of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USAEnteric & Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, 500 5th Ave. N, Seattle, WA 98109, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USADivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USABloodstream infections in low- and middle-income countries (LMICs) are most frequently attributed to invasive Salmonella disease caused by four primary serovars of <i>Salmonella</i> enterica: Typhi, Paratyphi A, Typhimurium, and Enteritidis. We showed previously that a bivalent vaccine targeting <i>S</i>. Typhi and <i>S</i>. Paratyphi A using a Multiple Antigen-Presenting System (MAPS) induced functional antibodies against <i>S</i>. Typhi and <i>S</i>. Paratyphi. In the current study, we describe the preclinical development of a first candidate quadrivalent combination <i>Salmonella</i> vaccine with the potential to cover all four leading invasive <i>Salmonella</i> serotypes. We showed that the quadrivalent <i>Salmonella</i> MAPS vaccine, containing Vi from <i>S</i>. Typhi, O-specific Polysaccharide (OSP) from <i>S.</i> Paratyphi A, <i>S.</i> Enteritidis and <i>S.</i> Typhimurium, combined with the <i>Salmonella</i>-specific protein SseB, elicits robust and functional antibody responses to each of the components of the vaccine. Our data indicates that the application of MAPS technology to the development of vaccines targeting invasive forms of Salmonella is practical and merits additional consideration.https://www.mdpi.com/2076-393X/11/11/1671SalmonellaMAPS vaccineOSPSseBquadrivalentTyphimurium
spellingShingle Emily M. Boerth
Joyce Gong
Becky Roffler
Claudette M. Thompson
Boni Song
Sasha F. Malley
Angelika Hirsch
Calman A. MacLennan
Fan Zhang
Richard Malley
Ying-Jie Lu
Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A
Vaccines
Salmonella
MAPS vaccine
OSP
SseB
quadrivalent
Typhimurium
title Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A
title_full Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A
title_fullStr Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A
title_full_unstemmed Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A
title_short Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A
title_sort induction of broad immunity against invasive salmonella disease by a quadrivalent combination salmonella maps vaccine targeting salmonella enterica serovars typhimurium enteritidis typhi and paratyphi a
topic Salmonella
MAPS vaccine
OSP
SseB
quadrivalent
Typhimurium
url https://www.mdpi.com/2076-393X/11/11/1671
work_keys_str_mv AT emilymboerth inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT joycegong inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT beckyroffler inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT claudettemthompson inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT bonisong inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT sashafmalley inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT angelikahirsch inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT calmanamaclennan inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT fanzhang inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT richardmalley inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia
AT yingjielu inductionofbroadimmunityagainstinvasivesalmonelladiseasebyaquadrivalentcombinationsalmonellamapsvaccinetargetingsalmonellaentericaserovarstyphimuriumenteritidistyphiandparatyphia